Severe Asthma NFZ — 73 facilities in 54 cities

Severe asthma is a form of bronchial asthma that cannot be controlled with standard inhaled medications. It causes frequent exacerbations, breathlessness, coughing, and limited physical activity. The NFZ covers pulmonological diagnostics, inhaled medications, systemic corticosteroids, and biological therapy including omalizumab, mepolizumab, benralizumab, dupilumab, and tezepelumab through drug programs.